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Cystic Fibrosis (CF) is a respiratory tract disease in which
impairment of mucociliairy clearance and innate defense
mechanisms lead to susceptibility to chronic inflammation and
hence lung injury and fibrosis.
Although Staphylococcus aureus and Haemophilus influenzae
initially colonize CF patients, Pseudomonas aeruginosa (PA) is the
most prevalent adulthood CF pathogen. Current diagnostic
techniques lack sensitivity and commonly miss early infection,
especially in young children. A sensitive and specific noninvasive
technique for the diagnosis of PA infection would be helpful in
treatment.
Breath analysis offers great potential as a non-invasive method
for diagnosis of lower respiratory tract infections without the need
for bronchoscopy or alveolar lavage. This study wants to investigate
the possible use of IMS in early detection of CF infection.
Fifteen CF patients (53.3% male, age 31.07 (6.91)) and 15
Healthy controls (46.7% male, age 33.33 (5.43)) were included.
Breath samples were collected after breathing tidally for 3 minutes
through a mouthpiece connected to a VOC-filter and a 6-way valve.
Ten ml alveolar air was collected and immediately analyzed with a
MCC-IMS (B&S Analytik, Dortmund, Germany).
Fifty-seven peaks were selected manually using the software
VisualNow v3.4. Through peak analysis the presence and intensity of
the VOCs were obtained and compared using the statistical software
SPSS v21.
• No significant differences were found in age and gender between CF patients and controls.
• Three peaks were found statistically significant increased in the breath of CF patients and were
associated with CF: P7, P19 and P43 (figure 1).
Peaksa Odds Ratiob 95% CI p-value Rt (s) 1/K0 (Vs/cm²)
P7 5.18 1.4 - 19.1 0.013 6.1 0.579
P19 211.72 2.4 - 1816.9 0.019 3.8 0.585
P43 20.83 1.4 - 316.9 0.029 32.1 0.824
• Three peaks were found to be associated with CF (P7, P19 and P43). 
• Further GC-MS analysis could provide the identity of the VOCs and relate them to pathogenesis or 
exacerbation of the disease due to infection. 
• Early detection of those peaks could possibly improve patient treatment and hospital time.
Fig 1: Standardized intensity (V) of VOCs in breath of CF patients.
Table I: Odds ratio for CF when having the peak.
*Contact: De Pintelaan 185, 9000 Ghent, Belgium, kevin.lamote@uzgent.be.
aStandardized. bAdjusted for age and gender. CI = Confidence Interval. Rt = Retention Time. 1/K0: Inverse Reduced  Ion Mobility.
